CTLA4-CD28 fusion was reported in a study as a highly frequent alteration in T-cell lymphomas (AITL, PTCL-NOS, NKTCL) with an overall frequency of 38% [77]. Here, CD28 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.